Stock Comparison

ARGX vs VRDN

argenx NV ADR and Viridian Therapeutics Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

VRDN

Viridian Therapeutics Inc

Healthcare

Valuation

Market Cap

$53.23B

$2.55B

P/E (TTM)

32.7

—

Forward P/E

30.4

1.0

Price/Sales

10.0

35.8

Price/Book

6.4

4.5

EV/EBITDA

27.6

-3.0

Dividend Yield

—

Profitability

Net Margin

30.44%

-508.46%

Operating Margin

27.34%

-543.86%

Return on Equity

23.60%

-65.70%

Return on Assets

11.60%

-30.20%

Growth (YoY)

Revenue Growth

59.30%

278.70%

Earnings Growth

95.20%

0.00%

Price & Risk

Beta

-0.0

0.9

52-Week High

$939.68

$33.78

52-Week Low

$652.43

$13.30

Analyst Target

$1,085.78

$36.62

Compare ARGX and VRDN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.